PLEASANTON, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI data processing for the healthcare and life sciences industries, today announced that its new ransomware prevention and protection initiative launched earlier this month is drawing initial interest and support from numerous health system clients seeking critical tools and guidance for preventing and responding to ransomware incidents. The Company is servicing multiple contract agreements for cloud backup and disaster recovery, enabling hospitals and health systems to move disaster recovery to the Amazon Web Services (AWS) cloud to secure resources and scale on demand. This helps to mitigate risks by increasing resilience and meeting compliance requirements. Elastic disaster recovery minimizes downtime with minimal RPO (recovery point objective) and RTO (recovery time objective) for immediate recovery to ransomware events.
“The accelerating volume of national news about ransomware incidents is driving widespread demand for cybersecurity services. Our clients are seeking guidance and protection from solutions that are specific to the concerns and needs of healthcare systems and their patients,” said Lena Kannappan, head of business, strategy and partnerships for Healthcare Triangle. In July alone, one of the country’s largest providers confirmed a data breach impacting 11 hospitals and 12 million patients, and now faces at least four class action lawsuits. A prominent community hospital had to close its doors permanently due to a 2021 ransomware attack that caused devastating financial loss. IBM reported that ‘the average costs of a studied breach in healthcare reached nearly $11 million in 2023 – a 53% price increase since 2020.’ Rural hospitals are particularly vulnerable to risk at these high costs.
“Healthcare Triangle’s mission is to fill a leadership role as the authority on specialized cybersecurity and identity management solutions for organizations ranging from small community healthcare providers to large healthcare systems serving millions of patients. We are in discussions with multiple cybersecurity product vendors and public cloud providers to bring best-of-breed solutions to the hospital community,” Kannappan continued. “In just two weeks, our initiative has drawn a significant amount of interest from our existing health system clients and partners. This strong initial response bodes well for the continuing adoption of our critical resources for preparedness, prevention, detection, response, and recovery from ransomware attacks.”
Key areas of client interest to date include:
Commenting on Healthcare Triangle’s ransomware initiative, longstanding client CalvertHealth Medical Center stated, “Hospitals need to take solid steps toward ransomware resilience. With HCTI’s help we have implemented their Amazon Web Services-based disaster recovery solution in order to protect our patients' data.”
For more information about Healthcare Triangle’s ransomware initiative, contact This email address is being protected from spambots. You need JavaScript enabled to view it..
About Healthcare Triangle
Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, identity management, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Prospectus filed with the SEC on October 7, 2021, previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Contacts
Media:
Michael Campana
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investors:
1-800-617-9550
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.74 |
Daily Change: | -0.04 -4.85 |
Daily Volume: | 16,845 |
Market Cap: | US$4.200M |
April 04, 2024 April 03, 2024 March 12, 2024 February 14, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB